NASDAQ
Integrated BioPharma, Inc. (INBP) has a fcf yield of 17.33% as of Friday, May 29, 2026. This represents a 37.58% increase compared to its 12-month average of 12.59%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.